Bruna Calsina

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.

MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 01, 2024

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes.

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes.

Journal: Cancer discovery

Published: July 04, 2024

SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population.

SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population.

Journal: Database : the journal of biological databases and curation

Published: April 02, 2024

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives.

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives.

Journal: Endocrine reviews

Published: October 17, 2023

Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.

Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.

Journal: Endocrine-related cancer

Published: July 17, 2023

Genetic bases of pheochromocytoma and paraganglioma.

Genetic bases of pheochromocytoma and paraganglioma.

Journal: Journal of molecular endocrinology

Published: December 01, 2022

DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.

DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.

Journal: Cancer communications (London, England)

Published: September 28, 2022

Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.

Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.

Journal: International journal of cancer

Published: June 03, 2022

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.

Journal: Nature communications

Published: May 05, 2022

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma.

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma.

Journal: Cancers

Published: August 26, 2021

Therapeutic Potential of Nitric Oxide‒Releasing Selective Estrogen Receptor Modulators in Malignant Melanoma.

Therapeutic Potential of Nitric Oxide‒Releasing Selective Estrogen Receptor Modulators in Malignant Melanoma.

Journal: The Journal of investigative dermatology

Published: April 05, 2021

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Journal: Cancers

Published: September 28, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026